메뉴 건너뛰기




Volumn 44, Issue 8-9, 2011, Pages 601-604

Increased levels of soluble receptor for advanced glycation end products (sRAGE) and high mobility group box 1 (HMGB1) are associated with death in patients with acute respiratory distress syndrome

Author keywords

ARDS; HMGB1; sRAGE

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6;

EID: 79955788043     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.12.014     Document Type: Article
Times cited : (68)

References (39)
  • 1
    • 43349104741 scopus 로고    scopus 로고
    • Advances in mechanisms of repair and remodelling in acute lung injury
    • Dos Santos C.C. Advances in mechanisms of repair and remodelling in acute lung injury. Intensive Care Med. 2008, 34:619-630.
    • (2008) Intensive Care Med. , vol.34 , pp. 619-630
    • Dos Santos, C.C.1
  • 3
    • 0033796308 scopus 로고    scopus 로고
    • Pulmonary pathology of acute respiratory distress syndrome
    • Tomashefski J.F. Pulmonary pathology of acute respiratory distress syndrome. Clin. Chest Med. 2000, 21:435-466.
    • (2000) Clin. Chest Med. , vol.21 , pp. 435-466
    • Tomashefski, J.F.1
  • 4
    • 0141926684 scopus 로고    scopus 로고
    • The pathophysiology of acute respiratory distress syndrome
    • Dechert R.E. The pathophysiology of acute respiratory distress syndrome. Respir. Care Clin. N. Am. 2003, 9:283-296.
    • (2003) Respir. Care Clin. N. Am. , vol.9 , pp. 283-296
    • Dechert, R.E.1
  • 5
    • 0035018051 scopus 로고    scopus 로고
    • Acute lung injury: cellular mechanisms and derangements
    • Schwarz M.A. Acute lung injury: cellular mechanisms and derangements. Paediatr. Respir. Rev. 2001, 2:3-9.
    • (2001) Paediatr. Respir. Rev. , vol.2 , pp. 3-9
    • Schwarz, M.A.1
  • 6
    • 67651099181 scopus 로고    scopus 로고
    • Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease
    • Yamagishi S., Nakamura K., Matsui T. Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease. Pharmacol. Res. 2009, 60:174-178.
    • (2009) Pharmacol. Res. , vol.60 , pp. 174-178
    • Yamagishi, S.1    Nakamura, K.2    Matsui, T.3
  • 7
    • 77957583005 scopus 로고    scopus 로고
    • The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?
    • Creagh-Brown B.C., Quinlan G.J., Evans T.W., Burke-Gaffney A. The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?. Intensive Care Med. 2010, 36:1644-1656.
    • (2010) Intensive Care Med. , vol.36 , pp. 1644-1656
    • Creagh-Brown, B.C.1    Quinlan, G.J.2    Evans, T.W.3    Burke-Gaffney, A.4
  • 9
    • 77955703092 scopus 로고    scopus 로고
    • RAGE: a multi-ligand receptor unveiling novel insights in health and disease
    • Alexiou P., Chatzopoulou M., Pegklidou K., Demopoulos V.J. RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr. Med. Chem. 2010, 21:2232-2252.
    • (2010) Curr. Med. Chem. , vol.21 , pp. 2232-2252
    • Alexiou, P.1    Chatzopoulou, M.2    Pegklidou, K.3    Demopoulos, V.J.4
  • 10
    • 0034795140 scopus 로고    scopus 로고
    • The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
    • Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 2001, 108:949-955.
    • (2001) J. Clin. Invest. , vol.108 , pp. 949-955
    • Schmidt, A.M.1    Yan, S.D.2    Yan, S.F.3    Stern, D.M.4
  • 11
    • 0037769813 scopus 로고    scopus 로고
    • Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells
    • Fiuza C., Bustin M., Talwar S., et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood 2003, 101:2652-2660.
    • (2003) Blood , vol.101 , pp. 2652-2660
    • Fiuza, C.1    Bustin, M.2    Talwar, S.3
  • 12
    • 1542285224 scopus 로고    scopus 로고
    • Amphoterin as an extracellular regulator of cell motility: from discovery to disease
    • Huttunen H.J., Rauvala H. Amphoterin as an extracellular regulator of cell motility: from discovery to disease. J. Intern. Med. 2004, 255:351-366.
    • (2004) J. Intern. Med. , vol.255 , pp. 351-366
    • Huttunen, H.J.1    Rauvala, H.2
  • 13
    • 0034664791 scopus 로고    scopus 로고
    • Cutting edge: HMGB1 as a mediator of acute lung inflammation
    • Abraham E., Arcaroli J., Carmody A., Wang H., Tracey K.J. Cutting edge: HMGB1 as a mediator of acute lung inflammation. J. Immunol. 2000, 165:2950-2954.
    • (2000) J. Immunol. , vol.165 , pp. 2950-2954
    • Abraham, E.1    Arcaroli, J.2    Carmody, A.3    Wang, H.4    Tracey, K.J.5
  • 14
    • 34547094102 scopus 로고    scopus 로고
    • High-mobility group box 1 protein plasma concentrations during septic shock
    • Gibot S., Massin F., Cravoisy A., et al. High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med. 2007, 33:1347-1353.
    • (2007) Intensive Care Med. , vol.33 , pp. 1347-1353
    • Gibot, S.1    Massin, F.2    Cravoisy, A.3
  • 15
    • 33947660493 scopus 로고    scopus 로고
    • High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study
    • Gaini S., Pedersen S.S., Koldkjaer O.G., Pedersen C., Moller H.J. High mobility group box-1 protein in patients with suspected community-acquired infections and sepsis: a prospective study. Crit. Care 2007, 11:R32.
    • (2007) Crit. Care , vol.11
    • Gaini, S.1    Pedersen, S.S.2    Koldkjaer, O.G.3    Pedersen, C.4    Moller, H.J.5
  • 16
    • 48949095796 scopus 로고    scopus 로고
    • Role of soluble receptor for advanced glycation end products on exdotoxin-induced lung injury
    • Zhang H., Tasaka S., Shiraishi Y., et al. Role of soluble receptor for advanced glycation end products on exdotoxin-induced lung injury. Am. J. Respir. Crit. Care Med. 2008, 178:356-362.
    • (2008) Am. J. Respir. Crit. Care Med. , vol.178 , pp. 356-362
    • Zhang, H.1    Tasaka, S.2    Shiraishi, Y.3
  • 17
    • 38349179648 scopus 로고    scopus 로고
    • Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging
    • Yan S.F., D'Agati V., Schmidt A.M., Ramasamy R. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging. Curr. Mol. Med. 2007, 7:699-710.
    • (2007) Curr. Mol. Med. , vol.7 , pp. 699-710
    • Yan, S.F.1    D'Agati, V.2    Schmidt, A.M.3    Ramasamy, R.4
  • 18
    • 77957345420 scopus 로고    scopus 로고
    • Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker
    • Yamagishi S., Matsui T. Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker. Front. Biosci. 2010, 2:1184-1195.
    • (2010) Front. Biosci. , vol.2 , pp. 1184-1195
    • Yamagishi, S.1    Matsui, T.2
  • 19
    • 21644479206 scopus 로고    scopus 로고
    • Soluble RAGE: a hot new biomarker for the hot joint?
    • Moser B., Hudson B.I., Schmidt A.M. Soluble RAGE: a hot new biomarker for the hot joint?. Arthritis Res. Ther. 2005, 7:142-144.
    • (2005) Arthritis Res. Ther. , vol.7 , pp. 142-144
    • Moser, B.1    Hudson, B.I.2    Schmidt, A.M.3
  • 20
    • 33646243227 scopus 로고    scopus 로고
    • Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury
    • Uchida T., Shirasawa M., Ware L.B., et al. Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am. J. Respir. Crit. Care Med. 2006, 173:1008-1015.
    • (2006) Am. J. Respir. Crit. Care Med. , vol.173 , pp. 1008-1015
    • Uchida, T.1    Shirasawa, M.2    Ware, L.B.3
  • 21
    • 67650069965 scopus 로고    scopus 로고
    • Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury
    • Su X., Looney M.R., Gupta N., Matthay M.A. Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 297:L1-L5.
    • (2009) Am. J. Physiol. Lung Cell. Mol. Physiol. , vol.297
    • Su, X.1    Looney, M.R.2    Gupta, N.3    Matthay, M.A.4
  • 22
    • 0028267785 scopus 로고
    • The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination
    • Bernard G.R., Artigas A., Brigham K.L., et al. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes and clinical trial coordination. Am. J. Respir. Crit. Care Med. 1994, 149:818-824.
    • (1994) Am. J. Respir. Crit. Care Med. , vol.149 , pp. 818-824
    • Bernard, G.R.1    Artigas, A.2    Brigham, K.L.3
  • 23
    • 0022256529 scopus 로고
    • APACHE II: a severity of disease classification system
    • Knaus W., Draper E., Wagner D., Zimmerman J. APACHE II: a severity of disease classification system. Crit. Care Med. 1985, 13:818-829.
    • (1985) Crit. Care Med. , vol.13 , pp. 818-829
    • Knaus, W.1    Draper, E.2    Wagner, D.3    Zimmerman, J.4
  • 24
  • 25
    • 2442676627 scopus 로고    scopus 로고
    • Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome
    • Ishizaka A., Matsuda T., Albertine K.H., et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 286:L1088-L1094.
    • (2004) Am. J. Physiol. Lung Cell. Mol. Physiol. , vol.286
    • Ishizaka, A.1    Matsuda, T.2    Albertine, K.H.3
  • 27
    • 70350168702 scopus 로고    scopus 로고
    • Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock
    • Nakamura K., Sato E., Fujiwara N., et al. Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock. Pharmacol. Res. 2009, 60:515-518.
    • (2009) Pharmacol. Res. , vol.60 , pp. 515-518
    • Nakamura, K.1    Sato, E.2    Fujiwara, N.3
  • 28
    • 39649118422 scopus 로고    scopus 로고
    • Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes
    • Nakamura K., Yamagishi S., Adachi H., et al. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes. Diabetes Metab. Res. Rev. 2008, 24:109-114.
    • (2008) Diabetes Metab. Res. Rev. , vol.24 , pp. 109-114
    • Nakamura, K.1    Yamagishi, S.2    Adachi, H.3
  • 29
    • 57149101367 scopus 로고    scopus 로고
    • NHLBI ARDS Network, plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury
    • Calfee C.S., Ware L.B., Eisner M.D., et al. NHLBI ARDS Network, plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 2008, 63:1083-1089.
    • (2008) Thorax , vol.63 , pp. 1083-1089
    • Calfee, C.S.1    Ware, L.B.2    Eisner, M.D.3
  • 30
    • 0343893748 scopus 로고    scopus 로고
    • The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
    • The acute respiratory distress syndrome network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N. Engl. J. Med. 2000, 342:1301-1308.
    • (2000) N. Engl. J. Med. , vol.342 , pp. 1301-1308
  • 31
    • 54049108485 scopus 로고    scopus 로고
    • A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
    • Raucci A., Cugusi S., Antonelli A., et al. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 2008, 22:3716-3727.
    • (2008) FASEB J. , vol.22 , pp. 3716-3727
    • Raucci, A.1    Cugusi, S.2    Antonelli, A.3
  • 32
    • 27744574284 scopus 로고    scopus 로고
    • Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension
    • Nakamura K., Yamagishi S., Nakamura Y., et al. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension. Microvasc. Res. 2005, 70:137-141.
    • (2005) Microvasc. Res. , vol.70 , pp. 137-141
    • Nakamura, K.1    Yamagishi, S.2    Nakamura, Y.3
  • 33
    • 33947408459 scopus 로고    scopus 로고
    • Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes
    • Tan K.C., Shiu S.W., Chow W.S., Leng L., Bucala R., Betteridge D.J. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Diabetologia 2006, 49:2756-2762.
    • (2006) Diabetologia , vol.49 , pp. 2756-2762
    • Tan, K.C.1    Shiu, S.W.2    Chow, W.S.3    Leng, L.4    Bucala, R.5    Betteridge, D.J.6
  • 34
    • 33947386181 scopus 로고    scopus 로고
    • Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
    • Humpert P.M., Djuric Z., Kopf S., et al. Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes. Cardiovasc. Diabetol. 2007, 6:9.
    • (2007) Cardiovasc. Diabetol. , vol.6 , pp. 9
    • Humpert, P.M.1    Djuric, Z.2    Kopf, S.3
  • 35
    • 45449083028 scopus 로고    scopus 로고
    • Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes
    • Nakamura K., Yamagishi S., Adachi H., et al. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes. Microvasc. Res. 2008, 76:52-56.
    • (2008) Microvasc. Res. , vol.76 , pp. 52-56
    • Nakamura, K.1    Yamagishi, S.2    Adachi, H.3
  • 36
    • 34250675234 scopus 로고    scopus 로고
    • Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes
    • Nakamura K., Yamagishi S., Adachi H., et al. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol. Med. 2007, 13:185-189.
    • (2007) Mol. Med. , vol.13 , pp. 185-189
    • Nakamura, K.1    Yamagishi, S.2    Adachi, H.3
  • 37
    • 0033538467 scopus 로고    scopus 로고
    • HMG-1 as a late mediator of endotoxin lethality in mice
    • Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
    • (1999) Science , vol.285 , pp. 248-251
    • Wang, H.1    Bloom, O.2    Zhang, M.3
  • 38
    • 45549107924 scopus 로고    scopus 로고
    • Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
    • Bopp C., Bierhaus A., Hofer S., et al. Bench-to-bedside review: the inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis. Crit. Care 2008, 12:201.
    • (2008) Crit. Care , vol.12 , pp. 201
    • Bopp, C.1    Bierhaus, A.2    Hofer, S.3
  • 39
    • 43049145039 scopus 로고    scopus 로고
    • SRAGE is elevated in septic patients and associated with patients outcome
    • Bopp C., Hofer S., Weitz J., et al. sRAGE is elevated in septic patients and associated with patients outcome. J. Surg. Res. 2008, 147:79-83.
    • (2008) J. Surg. Res. , vol.147 , pp. 79-83
    • Bopp, C.1    Hofer, S.2    Weitz, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.